Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Ieee Internet of Things Journal ; 10(1):144-165, 2023.
Article in English | Web of Science | ID: covidwho-2237279

ABSTRACT

Throughout human history, deadly infectious diseases emerged occasionally. Even with the present-day advanced healthcare systems, the COVID-19 has caused more than six million deaths worldwide (as of 27 July 2022). Currently, researchers are working to develop tools for better and effective management of the pandemic. "Contact tracing " is one such tool to monitor and control the spread of the disease. However, manual contact tracing is labor-intensive and time-consuming. Therefore, manually tracking all potentially infected individuals is a great challenge, especially for an infectious disease like COVID-19. To date, many digital contact tracing applications were developed and used globally to restrain the spread of COVID-19. In this work, we perform a detailed review of the current digital contact tracing technologies. We mention some of their key limitations and propose a fully integrated system for contact tracing of infectious diseases using COVID-19 as a case study. Our system has four main modules-1) case maps;2) exposure detection;3) screening;and 4) health indicators that take multiple inputs like users' self-reported information, measurement of physiological parameters, and information of the confirmed cases from the public health, and keeps a record of contact histories using Bluetooth technology. The system can potentially evaluate the users' risk of getting infected and generate notifications to alert them about the exposure events, risk of infection, or abnormal health indicators. The system further integrates the Web-based information on confirmed COVID-19 cases and screening tools, which potentially increases the adoption rate of the system.

2.
IEEE Internet of Things Journal ; : 1-1, 2022.
Article in English | Scopus | ID: covidwho-2018948

ABSTRACT

Throughout human history, deadly infectious diseases emerged occasionally. Even with the present-day advanced healthcare systems, the COVID-19 has caused more than six million deaths worldwide (as of 27 July 2022). Currently, researchers are working to develop tools for better and effective management of the pandemic. ’Contact tracing’is one such tool to monitor and control the spread of the disease. However, manual contact tracing is labor-intensive and time-consuming. Therefore, manually tracking all potentially infected individuals is a great challenge, especially for an infectious disease like COIVD-19. To date, many digital contact tracing applications were developed and used globally to restrain the spread of COVID-19. In this work, we perform a detailed review of the current digital contact tracing technologies. We mention some of their key limitations and propose a fully integrated system for contact tracing of infectious diseases using COVID-19 as a case study. Our system has four main modules -Case Maps, Exposure Detection, Screening, and Health Indicators that takes multiple inputs like users’self-reported information, measurement of physiological parameters, and information of the confirmed cases from the public health, and keeps a record of contact histories using Bluetooth technology. The system can potentially evaluate the users’risk of getting infected and generate notifications to alert them about the exposure events, risk of infection, or abnormal health indicators. The system further integrates the web-based information on confirmed Covid-19 cases and screening tools, which potentially increases the adoption rate of the system. IEEE

3.
Res Sq ; 2020 May 13.
Article in English | MEDLINE | ID: covidwho-670716

ABSTRACT

World over, people are looking for solutions to tackle the pandemic coronavirus disease (COVID-19) caused by the virus SARS-CoV-2/nCoV-19. Notable contributions in biomedical field have been characterizing viral genomes, host transcriptomes and proteomes, repurposable drugs and vaccines. In one such study, 332 human proteins targeted by nCoV19 were identified. We expanded this set of host proteins by constructing their protein interactome, including in it not only the known protein-protein interactions (PPIs) but also novel, hitherto unknown PPIs predicted with our High-precision Protein-Protein Interaction Prediction (HiPPIP) model that was shown to be highly accurate. In fact, one of the earliest discoveries made possible by HiPPIP is related to activation of immunity upon viral infection. We found that several interactors of the host proteins are differentially expressed upon viral infection, are related to highly relevant pathways, and that the novel interaction of NUP98 with CHMP5 may activate an antiviral mechanism leading to disruption of viral budding. We are making the interactions available as downloadable files to facilitate future systems biology studies and also on a web-server at http://hagrid.dbmi.pitt.edu/corona that allows not only keyword search but also queries such as "PPIs where one protein is associated with 'virus' and the interactors with 'pulmonary'".

4.
Res Sq ; 2020 May 28.
Article in English | MEDLINE | ID: covidwho-670715

ABSTRACT

We previously presented the protein-protein interaction network - the 'HoP' or the host protein interactome - of 332 host proteins that were identified to interact with 27 nCoV19 viral proteins by Gordon et al. Here, we studied drugs targeting the proteins in this interactome to identify whether any of them may potentially be repurposable against SARS-CoV-2. We studied each of the drugs using the BaseSpace Correlation Engine and identified those that induce gene expression profiles negatively correlated with SARS-associated expression profile. This analysis resulted in 20 drugs whose differential gene expression (drug versus normal) had an anti-correlation with differential expression for SARS (viral infection versus normal). These included drugs that were already being tested for their clinical activity against SARS-CoV-2, those with proven activity against SARS-CoV/MERS-CoV, broad-spectrum antiviral drugs, and those identified/prioritized by other computational re-purposing studies. In summary, our integrated computational analysis of the HoP interactome in conjunction with drug-induced transcriptomic data resulted in drugs that may be repurposable for COVID-19.

SELECTION OF CITATIONS
SEARCH DETAIL